Nasdaq Biotechnology Ishares ETF (IBB) Stock Price, Quote & News

Company Profile

The fund generally will invest at least 80% of its assets in the component securities of its underlying index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.

Phone: 1-800-474-2737

BioAmerica Jun. 23 at 11:47 AM

$CRMD News today is pretty interesting. So, because the LDO has now started ordering, the 2Q25 projected revenue has been increased by $4M-$9M. It appears this increase only is based on the last week or so of the quarter. I can't wait to see how much they increase the full year revenue. This is what we have been waiting for. $XBI $IBB

1 · Reply

StocktwitsNews Jun. 23 at 7:47 AM

BNY, Northern Trust Rumored To Mull Potential Merger That Could Lead To ‘Monster’ Banking Deal — Retail’s Excited $NTRS $BK $VTI $IBB https://stocktwits.com/news/equity/markets/bny-northern-trust-rumored-to-mull-potential-merger/chmPwN3RR5S

0 · Reply

BioRich Jun. 23 at 3:20 AM

$ALT Is withholding material information an SEC violation or an FDA violation? GLTA $XBI $IBB $VKTX $GILD

2 · Reply

Darby53 Jun. 21 at 10:06 PM

$ALT $XBI $VKTX $IBB $TERN interesting take, correlating PR and website sloppiness with research data sloppiness is a stretch... Maybe those small things were overlooked because everyone was focused on the science

1 · Reply

BioRich Jun. 21 at 8:23 PM

$ALT So while most on this board are stuck in fantasy land, small things like ALT's disastrous PR abilities and games they play have likely scared any potential suitor away. Simple things like throwing together events on their page last second and out of order are the small things someone who is looking to spend $2B on raise flags about. While these things may seem small and insignificant, they are a gateway to sloppiness across the entire organization...i.e., data. I don't expect most on this page to understand that but it's a real concern, especially given $ALT's history. Folks, this is how we're different. Cheers! ~BioRich Capital $XBI $VKTX $IBB $TERN

2 · Reply

TalkMarkets Jun. 21 at 2:55 PM

Weekly Commentary: Back For A Second Attempt $IBB $IWM $SMH $NDX $DAX https://talkmarkets.com/content/stocks--equities/weekly-commentary-back-for-a-second-attempt?post=505088

0 · Reply

BioRich Jun. 20 at 1:27 PM

$ALT Can't wait for ALTers to throw this in my face, but in the meantime, it keeps getting better as the $GALT train is chugging along. Have Monday on a Friday. Follow for more suggestions and perspective. That's how we find these gems and learn. Let's make some money. Cheers! $GALT $XBI $IBB $QQQ

2 · Reply

Siuolman58 Jun. 19 at 1:53 PM

$IBB Please check out GLMD. Low float like 5M. Large short position. Lots of cash on hand. These guys have the Ozempic equal in Pill form! Its starting to move as of this month. Look at the chart. Could go Meme ballistic. Had a ton of action on Wednesday

0 · Reply

QuantLake Jun. 19 at 5:45 AM

Gold Miners Drop 0.95% as Tech Sectors Advance - Wednesday Market Moves: VanEck Semiconductor ($SMH) gained +0.38% iShares Biotechnology ($IBB) rose +0.36% iShares Bitcoin ($IBIT) dipped -0.89% VanEck Gold Miners ($GDX) slipped -0.95% Our View: $SMH: Bullish Momentum - Positive Sentiment. $IBB: Neutral Momentum - Neutral Sentiment. $IBIT: Bullish Momentum - Positive Sentiment. $GDX: Bullish Momentum - Positive Sentiment. US markets will be closed today for Juneteenth National Independence Day.

0 · Reply

topstockalerts Jun. 18 at 7:10 PM

$VOYG $CAI $IBB $CHYM Biotech is back in focus as Caris Life Sciences (CAI +26.52%) surged in its IPO, opening at $27 (up 28.6% from its $21 offer) and reaching $29.40 intraday. Its $7.6B market cap puts it ahead of most stocks in the biotech ETF (IBB +0.45%). Caris raised $ 494M via 23.53M shares, priced above range, backed by top underwriters. It joins recent debuts like CHYM, VOYG, and CRCL, showing strong investor demand for fresh, high-profile listings. Q1 losses narrowed to $102.6M as revenue rose 50% to $120.9M. From 2019–2024, revenue grew 28% annually. Caris, with 1,769 staff, uses AI and a vast genomic database to personalize cancer treatment and aims to expand into chronic disease detection. It’s completed 6.5M tests, found 915K mutations, and customizes therapies per patient. Founder/CEO David Halbert owns 43.7% post-IPO; Sixth Street and J.H. Whitney VI hold 9% and 7.1%, respectively.

0 · Reply

Fast Money: WTI, IBB, UBER, CAT

UBER CAT

May 30, 2025, 3:30 PM EDT - 23 days ago

Healthcare Sector Checkup As U.S. Looks To Change Regulations

AGNG ARKG BBC BBH BBP BIB BIS

May 29, 2025, 10:59 AM EDT - 25 days ago

IBB: Now Is The Time To Be Contrarian

May 28, 2025, 12:22 PM EDT - 26 days ago

Jefferies' Michael Yee: Drug discovery could be one of the biggest beneficiaries of generative AI

AMGN BIIB DHR GILD ILMN NVS SDGR

May 13, 2025, 1:43 PM EDT - 5 weeks ago

Trump is right about drug prices. He's just going about it all wrong.

XBI XLV

May 7, 2025, 11:13 AM EDT - 6 weeks ago

New vaccine chief rocks pharmaceutical stocks

BNTX MRNA NVAX PFE GSK SRPT XBI

Apr 14, 2025, 2:03 PM EDT - 2 months ago

Trump Says Pharmaceutical Tariffs Coming in Near Future

ABBV AMGN AZN BMY GSK JNJ LLY

Apr 11, 2025, 7:17 PM EDT - 2 months ago

Sell into strength in pharma, says Mizuho's Jared Holz

XBI

Apr 11, 2025, 10:30 AM EDT - 2 months ago

Trump's pharmaceutical tariffs could raise costs for patients, worsen drug shortages

ABBV AMGN AZN BMY GSK JNJ LLY

Apr 11, 2025, 5:30 AM EDT - 2 months ago

How to Play the Biotech Meltdown in the Age of RFK Jr. and Tariffs

XBI

Apr 9, 2025, 6:32 PM EDT - 2 months ago

BMO's Siegerman talks the impact of tariffs on pharmaceutical stocks

ABBV AMGN AZN BMY GSK JNJ LLY

Apr 9, 2025, 2:27 PM EDT - 2 months ago

Explainer: Prescription drugs become a target in Trump's trade war

ABBV AMGN AZN BMY GSK JNJ LLY

Apr 9, 2025, 1:06 PM EDT - 2 months ago

Healthy Returns: Trump says major pharmaceutical tariffs coming ‘very shortly'

ABBV AMGN AZN BMY GSK JNJ LLY

Apr 9, 2025, 11:49 AM EDT - 2 months ago

Why drug stocks are no longer a safe haven from the stock market's turmoil

ABBV AMGN BMY JNJ LLY MRK PFE

Mar 2, 2025, 8:33 AM EST - 4 months ago

Invest In A New Biotech Bull Market With XBI And IBB

XBI

Feb 25, 2025, 11:06 AM EST - 4 months ago

Seeking Stocks With Vitality In The Volatile Healthcare Sector

XLV AGNG ARKG BBC BBH BBP BIB

Feb 3, 2025, 6:43 PM EST - 4 months ago

How tariffs could impact pharma and early-stage healthcare investments

XLV

Jan 30, 2025, 7:06 PM EST - 5 months ago

Biotech walks a 'tightrope' amid unclear funding, regulations

DCTH ELVN

Jan 13, 2025, 6:10 PM EST - 5 months ago

Top 5 Cancer Pharma Stocks With Strong Risk/Reward In 2025

ABBV AMGN AZN BNTX FBCG GILD GSK

Dec 10, 2024, 1:33 PM EST - 6 months ago

iShares Biotechnology ETF: Playing Defense

Nov 25, 2024, 6:44 PM EST - 7 months ago

Mizuho's Jared Holz on what Trump's FDA pick means for biotech innovation

HIMS LLY MRNA NVO PFE

Nov 25, 2024, 6:22 PM EST - 7 months ago

Health care stocks jump on Trump's nominee for FDA head

HIMS LFMD MRNA PFE

Nov 20, 2024, 6:21 PM EST - 7 months ago

Final Trade: Euro, IBB, SMH, NEM

SMH NEM

Nov 15, 2024, 6:54 PM EST - 7 months ago

Final Trade: West Pharma, Cameco, iShares Biotechnology ETF and Applied Digital Corp

APLD CCJ WST

Oct 14, 2024, 7:36 AM EDT - 9 months ago

IBB: A Near-20x P/E Is Historically Pricey, Technical Trends Neutral

Aug 30, 2024, 5:34 PM EDT - 10 months ago

Biotech Stocks Are Showing Signs of Life. Why the Rally Could Continue.

GILD XBI

Aug 12, 2024, 4:25 PM EDT - 11 months ago

Biotech stocks will get a tailwind from rate cuts, says Stempoint's Michelle Ross

LLY XBI

Jul 30, 2024, 3:25 PM EDT - 11 months ago

Analyst is 'extremely bullish' on biopharma

MRK PFE

Jul 28, 2024, 12:25 PM EDT - 11 months ago

iShares Biotechnology ETF: Significant Upside Potential As Sector Gains Momentum

Jul 9, 2024, 7:00 AM EDT - 1 year ago

Biotech Stocks 2024 Second Half Outlook - Buy Biotechs

XBI

May 13, 2024, 9:00 AM EDT - 1 year ago

For Biotech Stocks To Move Higher, This Must Move Lower

XBI

Apr 10, 2024, 9:27 AM EDT - 1 year ago

This weight-loss ETF has performed well in its first five months. How does it compare with cheaper alternatives?

AMGN ASND CYTK DXCM EW HRTS IHE

Apr 2, 2024, 4:56 PM EDT - 1 year ago

Biotech's Next Gold Rush: Weight-Loss Drugs

LLY NVO

Mar 28, 2024, 2:01 AM EDT - 1 year ago

Catch The Medical Breakthroughs With The IBB ETF

Mar 26, 2024, 4:46 AM EDT - 1 year ago

IBB: Let It Rest

Mar 9, 2024, 3:59 AM EST - 1 year ago

Why Biotech Stocks May Be Ready For A Recovery

BBH XLV

Feb 15, 2024, 1:44 PM EST - 1 year ago

Navigating the big run in biotech

XBI

Feb 8, 2024, 7:34 AM EST - 1 year ago

Health care's underperformance last year sets it up well for 2024, says Mara Goldstein

XLV

Jan 17, 2024, 11:22 PM EST - 1 year ago

Healthcare In 2024: Navigating The Biopharma Bull Run

FHLC IYH PPH VHT XBI XLV

Jan 5, 2024, 11:01 AM EST - 1 year ago

Equity CEFs/ETFs: Top Picks For 2024 - Part II

AIO AIQ BIB DIG EOI ETW EXG

Dec 27, 2023, 4:26 PM EST - 1 year ago

Dr. Scott Gottlieb talks Big Pharma's buying spree

XBI

Dec 26, 2023, 5:21 PM EST - 1 year ago

Wedbush's Laura Chico talks biotech investing in 2024

EWTX NBIX VRDN XBI

Dec 26, 2023, 1:40 PM EST - 1 year ago

Buy or bail on biotech: Here's what you need to know

XBI

Dec 26, 2023, 11:30 AM EST - 1 year ago

Biotech Stocks Are Breaking Out—and They Show No Sign of Slowing Down

XBI

Dec 15, 2023, 5:33 PM EST - 1 year ago

Wells Fargo's top pharma picks for 2024

ABBV AMGN BIIB LLY REGN VRTX

Dec 15, 2023, 10:00 AM EST - 1 year ago

We see Big Pharma going after smaller biotechs in 2024, says Jefferies' Michael Yee

MRK MRNA PFE

BioAmerica Jun. 23 at 11:47 AM

1 · Reply

StocktwitsNews Jun. 23 at 7:47 AM

0 · Reply

BioRich Jun. 23 at 3:20 AM

$ALT Is withholding material information an SEC violation or an FDA violation? GLTA $XBI $IBB $VKTX $GILD

2 · Reply

Darby53 Jun. 21 at 10:06 PM

1 · Reply

BioRich Jun. 21 at 8:23 PM

2 · Reply

TalkMarkets Jun. 21 at 2:55 PM

Weekly Commentary: Back For A Second Attempt $IBB $IWM $SMH $NDX $DAX https://talkmarkets.com/content/stocks--equities/weekly-commentary-back-for-a-second-attempt?post=505088

0 · Reply

BioRich Jun. 20 at 1:27 PM

2 · Reply

Siuolman58 Jun. 19 at 1:53 PM

0 · Reply

QuantLake Jun. 19 at 5:45 AM

0 · Reply

topstockalerts Jun. 18 at 7:10 PM

0 · Reply

gargoyl Jun. 18 at 3:27 PM

$BLRX she’s sneaking back up to $5 Watch and learn how patience is a virtue.. averaging in again , set up 👂 hear is $10 Target 🎯 $12 this year $XBI $IBB Longest the 🦋

0 · Reply

BioRich Jun. 18 at 12:44 PM

$GUTS Fractyl Receives 2 New U.S. patents "New U.S. patents strengthen Fractyl’s leadership in metabolic innovation by expanding its patent coverage of duodenal resurfacing, including thermal and non-thermal electrical energy applications". The steamroll of positive news continues on. This on the heels of new data this weekend makes this an impressively low cost buy opportunity. Follow/Subscribe for more suggestions and perspective. Would love to hear yours, too. That's how we find these gems and learn. Let's make some money. Cheers! $XBI $PFE $IBB $QQQ

1 · Reply

BioRich Jun. 17 at 6:32 PM

$ARVN Excellent news for Arvinas. Definitley a winner here. I know it's taken its hits but keeps plugged along. The science and pipeline are excellent. Extremely cheap at these Share Prices. Thanks @DonCorleone77 for sharing the write-up. Follow/Subscribe for more suggestions and perspective. That's how we find these gems and learn. Let's make some money. Cheers! ~BioRich Capital $XBI $QQQ $IBB

1 · Reply

Turribull Jun. 17 at 6:13 PM

$ALT $GALT $IBB $QQQ $XBI Your thinly veiled passive scorn for ALT bleeds from every post you make here. You’re a self-announced bag holder “trying to make your exit”. However, that admission juxtaposed against your chronic FUD posts suggest you’re either irretrievably illogical or you don’t understand how the stock market works. Either way, not one keystroke of yours moves the needle. Catharsis driven spam is wasting everyone else’s time. Good luck in your endeavors.

4 · Reply

BioRich Jun. 17 at 6:07 PM

$GALT I like a good Karma. Congrats to the GALT folks. Drop that G and make that money. Sorry $ALT. Just too fun. Hopefully you'll run too. Up 17% is nothing to sneeze at. Follow/Subscribe for more suggestions and perspective. Would love to hear yours, too. That's how we find these gems and learn. Let's make some money. Cheers! ~BioRich Capital $XBI $IBB $QQQ

2 · Reply

BioAmerica Jun. 17 at 4:04 PM

$XBI $IBB This is really big news for drug companies, and especially young ones with their first drug. Faster to approval equals not needing as much funding to get there. https://www.statnews.com/2025/06/17/fda-new-priority-reviews-will-cut-months-off-drug-approvals/

0 · Reply

TalkMarkets Jun. 16 at 9:41 PM

Agricultural #Commodities - Where’s The #Deflation In This? $DBA Also $IBB $IWM $IYT $KRE https://talkmarkets.com/content/commodities/agricultural-commodities-wheres-the-deflation-in-this?post=503583

0 · Reply

BioAmerica Jun. 16 at 11:58 AM

$IBB $XBI The price of MOST biotech stocks have little to do with the war in the middle east. Yet on Friday when the bombing started, many bios, including a lot of small bios, dropped. The decline continued through the rest of the day. Why? Because stupid people tried to link all stocks to the political climate at that moment. That was, and is, not reality. What it gives us all is the chance to buy some things that had become stretched. Now is the time to find those little gems that will thrive in the future. We all look for these situations everyday, but when they happen right in front of us, too many do the wrong thing and pull back. This war will end fast. And later there will be investors looking at the charts and wondering how they missed yet another opportunity.

1 · Reply

sister Jun. 15 at 9:22 PM

$MRNA wasn't this $170.47 last May? Coiled spring for 29.19 on FDA news on RSV vaccine expansion to At-Risk adults . $XLV $IBB

0 · Reply

TalkMarkets Jun. 15 at 2:36 PM

The Importance Of The 50-Week Moving Average $IBB $IWM $IYT $KRE $SMH https://talkmarkets.com/content/us-markets/the-importance-of-the-50-week-moving-average?post=502988

0 · Reply

BioRich Jun. 15 at 1:18 PM

$CAPR Jumping in with two feet at PPMD. For good reason as they look to take over the DMD space from $SRPT. Quite the exciting time. Disclosure, I absolutely love Sarepta and what they've done for these young men. Doug Ingram is about as savvy as it gets as a CEO (or at least was when I was following them closely). $SRPT is the reason I joined @Stocktwits and the reason I came up with this silly user name. That being said, it appears there's a changing of the guard and $CAPR is getting hot at the right time for the takeover as $SRPT faces future challenges. Again, thank you $SRPT, but it's time to move on to $CAPR and support them to the tilt to help these young men. Follow/Subscribe for more suggestions and perspective. Would love to hear yours, too. That's how we find these gems and learn. Let's make some money. Cheers! $XBI $IBB $IBBQ

1 · Reply

BioRich Jun. 13 at 11:42 PM

$XBI $CAPR BREAKING News! Capricor receives Orphan Drug Designation. https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=1079225 Congrats Longs! Follow/Subscribe for more suggestions and perspective. Would love to hear yours, too. That's how we find these gems and learn. Let's make some money. Cheers! ~BioRich Capital $IBB $SRPT $QQQ

1 · Reply

Market Cap	N/A
Revenue (ttm)	N/A
Net Income (ttm)	N/A
EPS (ttm)	N/A
PE Ratio	N/A
Forward PE	N/A
Profit Margin	N/A
Debt to Equity Ratio	N/A

Volume	552,023
Avg Vol	N/A
Day's Range	N/A - N/A
Shares Out	N/A
Stochastic %K	N/A
Beta	N/A
Analysts	N/A
Price Target	N/A